These data show that slow-cycling ADAM12+PDGFRα+αSMA– perivascular MSCs induced at early stages of tumorigenesis generate a discrete mesenchymal lineage that is maintained and active in advanced carcinomas and metastasis. This evidence concerns the gene ADAM12 and carcinoma.